Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacek Losy

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Neurology and Therapy|November 23, 2020
SARS-CoV-2 Infection: Symptoms of the Nervous System and Implications for Therapy in Neurological DisordersJacek Losy
Journal of Neural Transmission (Vienna, Austria : 1996)|September 24, 2013
Is MS an inflammatory or primary degenerative disease?Jacek Losy
Neuroimmunomodulation|August 20, 2010
CCL5, CXCL10 and CXCL11 chemokines in patients with active and stable relapsing-remitting multiple sclerosisAdam Szczuciński, Jacek Losy
Neurologia I Neurochirurgia Polska|March 30, 2004
[Cytokines in clinical and experimental ischemic stroke]Jarosław Zaremba, Jacek Losy
Przeglad Epidemiologiczny|August 17, 2006
[Infectious agents in the pathogenesis of multiple sclerosis]Adam Szczuciński, Jacek Losy
Reviews in the Neurosciences|January 16, 2019
Multiple sclerosis - the remarkable story of a baffling diseaseTomasz Grzegorski, Jacek Losy
Reviews in the Neurosciences|December 8, 2019
What do we currently know about the clinically isolated syndrome suggestive of multiple sclerosis? An updateTomasz Grzegorski, Jacek Losy
Folia Morphologica|March 22, 2002
Adhesion molecules of immunoglobulin gene superfamily in strokeJarosław Zaremba, Jacek Losy
Reviews in the Neurosciences|August 9, 2017
Cognitive impairment in multiple sclerosis - a review of current knowledge and recent researchTomasz Grzegorski, Jacek Losy
Acta Neurologica Scandinavica|February 14, 2007
Chemokines and chemokine receptors in multiple sclerosis. Potential targets for new therapiesAdam Szczuciński, Jacek Losy
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Neurology and Therapy|November 23, 2020
SARS-CoV-2 Infection: Symptoms of the Nervous System and Implications for Therapy in Neurological DisordersJacek Losy
Journal of Neural Transmission (Vienna, Austria : 1996)|September 24, 2013
Is MS an inflammatory or primary degenerative disease?Jacek Losy
Neuroimmunomodulation|August 20, 2010
CCL5, CXCL10 and CXCL11 chemokines in patients with active and stable relapsing-remitting multiple sclerosisAdam Szczuciński, Jacek Losy
Neurologia I Neurochirurgia Polska|March 30, 2004
[Cytokines in clinical and experimental ischemic stroke]Jarosław Zaremba, Jacek Losy
Przeglad Epidemiologiczny|August 17, 2006
[Infectious agents in the pathogenesis of multiple sclerosis]Adam Szczuciński, Jacek Losy
Reviews in the Neurosciences|January 16, 2019
Multiple sclerosis - the remarkable story of a baffling diseaseTomasz Grzegorski, Jacek Losy
Reviews in the Neurosciences|December 8, 2019
What do we currently know about the clinically isolated syndrome suggestive of multiple sclerosis? An updateTomasz Grzegorski, Jacek Losy
Folia Morphologica|March 22, 2002
Adhesion molecules of immunoglobulin gene superfamily in strokeJarosław Zaremba, Jacek Losy
Reviews in the Neurosciences|August 9, 2017
Cognitive impairment in multiple sclerosis - a review of current knowledge and recent researchTomasz Grzegorski, Jacek Losy
Acta Neurologica Scandinavica|February 14, 2007
Chemokines and chemokine receptors in multiple sclerosis. Potential targets for new therapiesAdam Szczuciński, Jacek Losy
Pageof 6